149 related articles for article (PubMed ID: 1657825)
1. Different mechanisms of protection by monoclonal and polyclonal antibodies during the course of herpes simplex virus infection.
Eis-Hübinger AM; Mohr K; Schneweis KE
Intervirology; 1991; 32(6):351-60. PubMed ID: 1657825
[TBL] [Abstract][Full Text] [Related]
2. Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes.
Eis-Hübinger AM; Schmidt DS; Schneweis KE
J Gen Virol; 1993 Mar; 74 ( Pt 3)():379-85. PubMed ID: 8383173
[TBL] [Abstract][Full Text] [Related]
3. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
Roberts PL; Duncan BE; Raybould TJ; Watson DH
J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
[TBL] [Abstract][Full Text] [Related]
4. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
Kümel G; Kaerner HC; Levine M; Schröder CH; Glorioso JC
J Virol; 1985 Dec; 56(3):930-7. PubMed ID: 2415719
[TBL] [Abstract][Full Text] [Related]
5. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
[TBL] [Abstract][Full Text] [Related]
7. Passive immune protection by herpes simplex virus-specific monoclonal antibodies with different plaque development inhibition activity.
Mannini-Palenzona A; Costanzo F; Cassai E; Campana G
New Microbiol; 1993 Jul; 16(3):205-13. PubMed ID: 8396193
[TBL] [Abstract][Full Text] [Related]
8. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
Chan WL; Lukig ML; Liew FY
J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein gB of herpes simplex virus expresses type-common and type-specific antigenic determinants in vivo.
Dix RD
J Med Virol; 1990 Mar; 30(3):192-5. PubMed ID: 1692872
[TBL] [Abstract][Full Text] [Related]
10. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies.
Mester JC; Glorioso JC; Rouse BT
J Infect Dis; 1991 Feb; 163(2):263-9. PubMed ID: 1846388
[TBL] [Abstract][Full Text] [Related]
11. Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine.
Kitces EN; Morahan PS; Tew JG; Murray BK
Infect Immun; 1977 Jun; 16(3):955-60. PubMed ID: 197013
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B.
Kohl S; Strynadka NC; Hodges RS; Pereira L
J Clin Invest; 1990 Jul; 86(1):273-8. PubMed ID: 2164044
[TBL] [Abstract][Full Text] [Related]
13. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
Dix RD; Pereira L; Baringer JR
Infect Immun; 1981 Oct; 34(1):192-9. PubMed ID: 6271681
[TBL] [Abstract][Full Text] [Related]
14. Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virus.
Kino Y; Eto T; Ohtomo N; Hayashi Y; Yamamoto M; Mori R
Microbiol Immunol; 1985; 29(2):143-9. PubMed ID: 2989659
[TBL] [Abstract][Full Text] [Related]
15. Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice.
Geerligs HJ; Kocken CH; Drijfhout JW; Weijer WJ; Bloemhoff W; Wilterdink JB; Welling GW; Welling-Wester S
J Gen Virol; 1990 Aug; 71 ( Pt 8)():1767-74. PubMed ID: 2167930
[TBL] [Abstract][Full Text] [Related]
16. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity.
Sanchez-Pescador L; Paz P; Navarro D; Pereira L; Kohl S
J Infect Dis; 1992 Sep; 166(3):623-7. PubMed ID: 1380051
[TBL] [Abstract][Full Text] [Related]
17. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.
Däumer MP; Schneider B; Giesen DM; Aziz S; Kaiser R; Kupfer B; Schneweis KE; Schneider-Mergener J; Reineke U; Matz B; Eis-Hübinger AM
Med Microbiol Immunol; 2011 May; 200(2):85-97. PubMed ID: 20931340
[TBL] [Abstract][Full Text] [Related]
19. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.
Balachandran N; Bacchetti S; Rawls WE
Infect Immun; 1982 Sep; 37(3):1132-7. PubMed ID: 6290390
[TBL] [Abstract][Full Text] [Related]
20. Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice.
Blacklaws BA; Nash AA
J Gen Virol; 1990 Apr; 71 ( Pt 4)():863-71. PubMed ID: 2157799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
